nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A constellation of complications:The metabolic syndrome
|
Grundy, Scott M. |
|
2005 |
7 |
2-3 |
p. 36-45 10 p. |
artikel |
2 |
Cardiometabolic risk assessment: An approach to the prevention of cardiovascular disease and diabetes mellitus
|
Vasudevan, Abu R. |
|
2005 |
7 |
2-3 |
p. 7-16 10 p. |
artikel |
3 |
Cardiometabolic risk management
|
|
|
2005 |
7 |
2-3 |
p. 2-4 3 p. |
artikel |
4 |
CME Test answers
|
|
|
2005 |
7 |
2-3 |
p. 81-83 3 p. |
artikel |
5 |
CME Test questions
|
|
|
2005 |
7 |
2-3 |
p. 75-78 4 p. |
artikel |
6 |
CME Test questions
|
|
|
2005 |
7 |
2-3 |
p. 79-80 2 p. |
artikel |
7 |
Commentary on current literature
|
Johnson, Richard A. |
|
2005 |
7 |
2-3 |
p. 74- 1 p. |
artikel |
8 |
Commentary on current literature
|
Johnson, Richard A. |
|
2005 |
7 |
2-3 |
p. 73- 1 p. |
artikel |
9 |
Introduction
|
Grundy, Scott M. |
|
2005 |
7 |
2-3 |
p. 6- 1 p. |
artikel |
10 |
Managing cardiovascular risk inpatients with metabolic syndrome
|
Nesto, Richard W |
|
2005 |
7 |
2-3 |
p. 46-51 6 p. |
artikel |
11 |
Pharmacotherapy to reducevisceral fat
|
Blackburn, George L. |
|
2005 |
7 |
2-3 |
p. 52-60 9 p. |
artikel |
12 |
The endocannabinoid system:A new approach to control cardiovascular disease
|
Cannon, Christopher P. |
|
2005 |
7 |
2-3 |
p. 17-26 10 p. |
artikel |
13 |
The metabolic basis of atherogenic dyslipidemia
|
Vinik, Aaron I. |
|
2005 |
7 |
2-3 |
p. 27-35 9 p. |
artikel |
14 |
The metabolic syndrome,hyperlipidemia, and insulin resistance
|
Fonseca, Vivian A |
|
2005 |
7 |
2-3 |
p. 61-72 12 p. |
artikel |